🚀 We're Hiring: Software Engineer for Machine Learning (m/f/d) at Aignostics! Are you an experienced Software Engineer for Machine Learning with a passion for AI in healthcare? Aignostics is seeking a talented individual to join our team as a Software Engineer for Machine Learning in Berlin. If you're ready to make an impact and shape the future of pathology, take a look at our open position for more information regarding what the role entails and requires and apply now! https://lnkd.in/dpTaQBgs #Hiring #MachineLearning #AI #Healthcare #Careers #Aignostics
Aignostics
Softwareentwicklung
Berlin, Berlin 5.987 Follower:innen
AI-powered precision diagnostics for pathology
Info
Aignostics combines proprietary access to multimodal clinical datasets, industry-leading AI technologies, and rigorous science to develop best-in-class insights for the next generation of precision medicine. Through collaborations with its biopharma partners, Aignostics supports drug discovery, translational research, clinical trials, and CDx development across multiple therapeutic areas. Established in 2018, Aignostics is a spin-off from Charité Berlin, one of the world’s largest and most esteemed university hospitals. Aignostics is funded by leading VC investors and has operations in Berlin and New York.
- Website
-
http://www.aignostics.com
Externer Link zu Aignostics
- Branche
- Softwareentwicklung
- Größe
- 51–200 Beschäftigte
- Hauptsitz
- Berlin, Berlin
- Art
- Privatunternehmen
- Gegründet
- 2018
- Spezialgebiete
- artificial intelligence, pathology, digital pathology, oncology, immuno-oncology, auto immune disease, neurodegenerative disease, improving medicine, companion diagnostics, precision medicine, solutions, R&D, computational pathology, predictive, deep learning, software engineering, translational research, target identification, healthcare und biomarkers
Orte
-
Primär
Alt-Moabit 73
Berlin, Berlin 10555, DE
Beschäftigte von Aignostics
Updates
-
What a great choice! Congratulations Kwadjo Nyante, MSc² , CISSP!
The Center would like to welcome Kwadjo Nyante, MSc² , CISSP to the Center’s Board of Trustees! Kwadjo Nyante, originally from Ghana, received multiple ISC2 scholarships from the Center to study abroad and has been living in Europe since 2016. With passion and determination, he attained two masters degrees in two years, graduating Cum Laude and Valedictorian from both. In under five years of working, he dramatically rose from Junior Security Engineer to Chief Information Security Officer (CISO), achieving the CISO title before 30 years of age. Kwadjo is currently CISO at Aignostics GmbH; an AI company based in Berlin and New York that turns complex biomedical data into transformative insights for leading biopharma companies. There, he develops innovative solutions to harmonize cutting-edge Artificial Intelligence with Medical and Data Security regulations. This directly improves the healthcare and research industry while protecting patient data. This is a full circle moment for the Center. We are thrilled to welcome Kwadjo Nyante, one of our past scholarship recipients, to the Board and look forward to how he will help shape the future of the organization. #board #trustee #volunteer #leadership #cybersecurity #center #nonprofit
-
-
Very proud of our Co-Founder Klauschen Frederick for this great honor!
Three outstanding #researchers from #LMU have been elected to the prestigious Leopoldina Academy of Sciences! 🌟 🧠 Prof. Dr. Klauschen Frederick, Director of the Institute of Pathology, is now a member of the Section of Pathology and Forensic Medicine. With his research at the interface of AI and medicine, he is making a decisive contribution to cancer research. 🔬 Prof. Dr. Claudia Bausewein, Director of the Clinic for Palliative Medicine at LMU University Hospital, is contributing her expertise in the field of palliative care to the Leopoldina's Global Health section. 🩺 Prof. Dr. Markus M. Lerch, Medical Director of LMU University Hospital, has been appointed to the Internal Medicine and Dermatology section of the academy. He specialises in the research and treatment of pancreatic diseases. Being elected to the Leopoldina is a great honour and underlines the high value of her research. We congratulate them and are delighted that they will continue to enrich the LMU Klinikum München and the scientific community! 🎉 https://lnkd.in/dS7DFD5t #Leopoldina #LMU #Medicine #Research #Science #PalliativeMedicine #Pathology #InternalMedicine #CancerResearch
Three LMU researchers elected to Leopoldina
lmu.de
-
We’re excited to be in Boston for the 14th World CB & CDx Summit next week! Our VP of Scientific Programs, Verena Aumiller will be giving a talk on September 6th at 11:55am on "Leveraging Computational Pathology for Target Identification & Biomarker R&D" as part of the Day Three Track A sessions. Join the session to learn more about novel multi-modal machine learning approaches for Target ID and Biomarker R&D as well as the role of foundation models today vs tomorrow. Want to learn more about the work we are doing? Reach out: https://lnkd.in/eM5b929E #WorldCDx #CDx #conference #boston #aignostics #precisionmedicine #healthtech #healthcare #innovation #AI #machinelearning #targetID #biomarker #foundationmodel
-
-
✨ We are excited to share that Aignostics has been chosen as one of the Top 10 AI for Business providers in Germany by The Spark 2024! Now, we need your vote to take home the grand prize. 🏆 ▶ Vote for us with just one click until September 15th: https://lnkd.in/esSj-e95 ℹ Why choose Aignostics? Our platform uses AI to combat the high failure rate of drug candidates and the low response rates of cancer immunotherapies. Through our leading machine learning model that uses multimodal AI and proprietary data sets, we work to significantly improve the identification of target molecules, biomarkers and indication selection for biopharma partners. We are honored to be recognized as one of the most innovative startups by an expert panel from Handelsblatt and McKinsey & Company and hope to have your support! #TheSpark24 #TheSpark #AIforBusiness #aignostics #award #vote #cancer #AI #precisionmedicine
-
-
Last week, our team gathered together in Berlin to enjoy the sunny summer weather at our Summer Team Event. ☀️There were many games, volleyball, food, and smiles all around. If this looks like fun to you, we are #hiring! Come join us as we further the future of precision medicine, while also having fun at the same time. https://lnkd.in/edMK3xv7
-
-
-
-
-
+1
-
-
Our team at Aignostics is proud to share that we have passed our 2024 ISO27001 audit with flying colors! We remain committed to maintaining a top-tier Information Security Management System that is compliant with GDPR and puts patient privacy at the forefront of everything we do. Major kudos to our whole team who take our commitment to Information Security very seriously, led by our CISO Kwadjo Nyante, MSc² , CISSP and Quality Manager Frank Münzinger.
-
-
We are excited to share that we have been included as one of the most promising German AI startups in this year's German AI Startup Landscape 2024 published by appliedAI Institute for Europe gGmbH! We are honored to be included among such inspiring companies and to be recognized for our work in the "Human Health" Industry category. We look forward to continuing our work bringing AI-powered solutions to precision medicine. Interested in our foundation model? Read more at: https://lnkd.in/d5283xUj #aignostics #precisionmedicine #ai #startup #foundationmodel #rudolfv
Veröffentlichung der 7. deutschen KI Startup Landscape 🚀 Das appliedAI Institute for Europe gGmbH präsentiert die 7. Ausgabe der deutschen KI-Startup Landscape, die umfassendste Analyse des deutschen KI-Startup-Ökosystems. Sei morgen um 15 Uhr dabei und erfahre aus erster Hand die Ergebnisse der Analyse in unserer Zoom-Session. Nehme teil und nutze die Chance direkt, um Fragen zu stellen: https://lnkd.in/dJR_2fFM. Highlights der Analyse: 🔍 Umfassende Analyse: Eine detaillierte Analyse über die deutsche KI-Startup-Szene. 🔒 Validierte Startups: Hochwertige, von Experti:innen validierte KI-Startups. 🤝 Ecosystem Building: Förderung der Zusammenarbeit zwischen Startups, Unternehmen und Regierung. Erfahre hier mehr über die KI-Startup-Szene in Deutschland auf unserer Website https://lnkd.in/dH5x5xe2. Ein herzliches Dankeschön geht an unsere Kontributoren, die die Entstehung dieser Analyse ermöglicht haben: Deutsche Telekom, NVIDIA, Intel Corporation, UnternehmerTUM, Cherry Ventures, Earlybird Venture Capital, UVC Partners, Yttrium, HTGF | High-Tech Gründerfonds, eCAPITAL ENTREPRENEURIAL PARTNERS, Burda Principal Investments, HV Capital, D11Z. Ventures GmbH & Co. KG, MIG Capital und AI.FUND. #AI #Startups #Innovation #Deutschland #KI Dr. Frauke Goll I Dr. Philip Hutchinson
-
-
AI algorithms in healthcare often perform well in controlled environments but struggle when dealing with real world variation. Foundation models are rapidly changing this paradigm and increasing the generalizability performance on downstream tasks without the need for larger labeled training datasets. Variation across scanners is a major challenge when developing digital pathology algorithms for the real world. To test scanner invariance of our foundation model (RudolfV), we evaluated a carcinoma-detection task across four common scanner types. Utilizing RudolfV showed that the representations of our model were robust across all scanner types. Ensuring robustness across scanner types can be extremely challenging without foundation models and provides just one example of how these models are rapidly accelerating the field of digital pathology. Interested in using our foundation model for your R&D and diagnostics development efforts? https://lnkd.in/d5283xUj #aignostics #rudolfv #foundationmodel #ai #artificialintelligence #histopathology #pathology #precisionmedicine
-
-
📣 Calling all Product Managers, our team is #hiring! We are hiring for two roles on our product management team - one junior product manager, and one senior product manager. These roles are both full-time and hybrid, based in Berlin. At Aignostics, we believe that AI has the potential to revolutionize how cancer and other complex diseases are diagnosed and treated. Come join our growing product team that will be directly involved in defining product strategy as we use AI to turn complex biomedical data into transformative insights for precision medicine. Senior Product Manager: https://lnkd.in/eq9_F8N5 Junior Product Manager: https://lnkd.in/etD56QDC #product #productmanagement #productmanager #nowhiring #hybrid #berlin #aignostics #AI #precisionmedicine #startup